Table 5.
Compounds | Origin | Antioxidant Effects | Test System | Dosage * | Reference |
---|---|---|---|---|---|
Dieckol | E. cava | Suppress UAB radiation induced photo-oxidative stress. | Human fibroblaste cell | 5, 50, 250 μM. | [59] |
Suppress UV-B radiation induced cell damages (both DNA damage and nuclear fragmentation). | Human fibroblaste cell | 5, 50, 250 μM. | |||
Diphlorethohydroxycarmalol (DPHC) | Brown algae. | DPHC can scavenge UV-B radiation induced ROS; with more DPHC added into the treatment, cell viability was uplifted. | Human fibroblast cells | 5, 50, 250 μM. | [62] |
Dieckol | E. cava | Suppress cell damage induced by UV-B radiation in vitro. Suppress the level of ROS, nitric oxide (NO) and cell death all stimulated by UV-B radiation. |
HaCaT cells | 5, 50, 100, and 250 μM. | [63] |
Phlorotannin extract (PE) | E. cava | Suppress levels of ROS and NO induced by UV-B radiation. In addition, cell death rate can be reduced by pre-treating zebra fish embryos with PE. | Zebra fish | 5, 50, 100, and 250 μM. | [63] |
Diphlorethohydroxycarmalol (DPHC) | I. okamurae | Suppress high glucose-induced oxidative stress. Suppress level of ROS (reactive oxygen species), NO (nitric oxide) induced by high glucose. |
Human umbilical vein endothelial cells | 5, 25, and 50 μM. | [105,118] |
Suppress high glucose induced inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and activation of nuclear factor-kappa B (NF-κB) activation. | Human umbilical vein endothelial cells | 5, 25, and 50 μM. |
* Blank was used as negative control in all the cited research.